You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 8,663,972


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,663,972
Title:Rhizopus oryzae strain, mutagenesis and screening methods thereof, and methods of fermenting to produce fumaric acid
Abstract: A rhizopus oryzae strain, mutagenesis and screening methods thereof, and methods of producing fumaric acid by fermentation. The strain is named as Rhizopus oryzae ME-F13, and deposited in China Center for Type Culture Collection with depository number CCTCC M 2010351. The strain is obtained by physically mutagenizing the original strain ME-F12 through ion injection, culturing the processed bacteria on the solid selective plate containing 2-D-deoxylucose (2-DG) and picking up 2-DG-resistant single colony. The strain is capable of simultaneously saccharifying starchy material and fermenting it to produce fumaric acid. With an improved enzymatic activity, the strain can be directly used to ferment raw starchy materials without needing pre-saccharifying.
Inventor(s): Huang; He (Jiangsu, CN), Li; Shuang (Jiangsu, CN), Xu; Qing (Jiangsu, CN), Gao; Zhen (Jiangsu, CN)
Assignee:
Application Number:13/992,233
Patent Claims:1. An isolated Rhizopus oryzae strain, with the classification and name Rhizopus oryzae ME-F13, deposited in the China Center for Type Culture Collection on Dec. 16, 2010 with the preservation number CCTCC No.: M 2010351.

2. A method of making the R. oryzae strain of claim 1, by mutating a Rhizopus oryzae strain and screening for glucoamylase production and fumaric acid production, comprising the following steps: a) obtaining the R. oryzae strain ME-UN-8 and mutating it by nitrogen ion implantation to yield mutant strains; b) obtaining spores from the mutant strains made in step (a); c) coating the spores obtained in step (b) onto a selective solid culture medium plate containing 2-deoxy-d-glucose (2-DG), to obtain strains with 2-DG resistance; d) culturing single colonies obtained from growth on the solid medium in step (c) in culture medium in shake flasks comprising starch as the carbon source; e) determining the level of glucoamylase activity of each flask culture and the amount of fumaric acid in each flask culture; and f) selecting the mutant having the highest increase of glucoamylase activity in its culture medium and of fumaric acid yield relative to the strain of step (a), wherein the selected mutant is named as Rhizopus oryzae ME-F13.

3. The method of claim 2, wherein the nitrogen ion implantation is N+ injection performed at an energy of 15 KeV and a dose of 50.times.10.sup.13 to 300.times.10.sup.13/cm.sup.2, and the operation pressure in the target chamber is 10.sup.-3 Pa.

4. The method of claim 2, wherein the solid selective culture medium comprises 0.2 g/L to 0.6 g/L of 2-DG.

5. The method of claim 2, wherein the solid culture medium containing 2-DG comprises 30 g/L of glycerol, 2 g/L of urea, 0.6 g/L of KH.sub.2PO.sub.4, 0.5 g/L of MgSO.sub.4.7H.sub.2O, 0.11 g/L of ZnSO.sub.4, 0.88 g/L of FeSO.sub.4.7H.sub.2O, and 20 g/L of agar.

6. A method of making fumaric acid, comprising the following steps: a) inoculating a seed medium with a suspension of spores of the Rhizopus oryzae ME-F13 strain of claim 1; b) culturing the inoculated seed medium; c) inoculating medium comprising starchy materials in a fermentation flask with the seed culture obtained in step (b), wherein the culture produces glucoamylase, wherein the glucoamylase hydrolyzes the starchy materials to make dextrin, and wherein the dextrin is a carbon source for the strain of step (a); d) culturing the inoculated medium in the flask, wherein the culture of the strain of step (a) produces fumaric acid; and e) isolating the fumaric acid made in step (d).

7. The method of claim 6, wherein the spore suspension is prepared by culturing the strain of claim 1 on agar slants for 6-7 days and washing off the resulting spores with sterile water.

8. The method of claim 6, wherein the inoculated seed medium is cultured at pH 2.5 to 2.7 for 28 h to 32 h.

9. The method of claim 6, wherein the seed culture of step (c) is inoculated into the flask in amount of 5-10% of the volume of the flask, and wherein the flask is cultured for 60 h to 85 h.

10. The method of claim 6, wherein the seed and fermentation media are prepared by mixing liquefied starchy materials and an inorganic salt, autoclaving the media at 115 to 121.degree. C. for 20 minutes, mixing the media after cooling, and add CaCO.sub.3 to fermentation medium to adjust the pH to a neutral pH.

11. The method of claim 10, wherein the seed and fermentation media are prepared by the following steps: a) mixing starchy materials with distilled water at a concentration of 8% to 12% (w/v) to make a suspension; b) heating the suspension to 70 degrees and then adding a thermostable amylase having an activity of 800 to 1000 U/g; c) incubating the mixture of step (b) for 10 minutes and then heating it to 90 degrees; d) measuring the amount of residual starch by a color reaction with iodine, wherein, when the blue coloration stays unchanged in the iodine test, the mixture is heated to 100 degrees and boiled for 5-10 minutes; e) filtering the liquid obtained in step (d) through two layers of gauze and cooling the filtrate; and f) diluting the filtrate to a concentration that can be used in fermentation.

12. The method of claim 6, wherein the starchy materials are selected from the group consisting of soluble starch, corn powder, degermed corn powder and cassava powder.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.